London (AP) — UK drug regulators to continue vaccination with AstraZeneca corona virus, despite revealing that seven UK people died of a rare blood clot after getting a jab I’m urging people.
The Medicines and Healthcare Products Regulatory Agency (MHRA) said it was not clear if Shot was causing blood clots and that “a rigorous review of the UK’s report on rare and specific types of blood clots is underway.”
Officials said late Friday that a blood clot had killed seven people, but did not provide information on age or health.
In total, MHRA said it identified 30 rare thrombotic events from the 18.1 million doses of AstraZeneca given by March 24. He added that the risks associated with this type of blood clot are “very small.”
“The benefits of COVID-19 vaccine AstraZeneca in the prevention of COVID-19 infection and its complications continue to outweigh the risks, and the general public must continue to be vaccinated when invited,” he said. Dr. June Rain, Chief Executive Officer of the authorities, said.
Concerns about the AstraZeneca vaccine have restricted its use to the elderly in some countries, such as Canada, France, Germany and the Netherlands.
The UK, which is deploying the coronavirus vaccine faster than other European countries, is particularly dependent on the AstraZeneca vaccine developed by scientists at the University of Oxford. It also uses a vaccine developed by Pfizer-BioNTech and the agency has not confirmed any reports of thrombotic events.
Saturday figures show that the UK has given 31.4 million people, or about 46% of the population, the first dose of the vaccine. This is a much higher percentage than in other parts of Europe. The April priority is the second dose, with 5.2 million people receiving two jabs.
The relative success of the country’s vaccination program is believed to have paved the way for significantly reducing new coronavirus infections in the United Kingdom after the winter surge and moderately relaxing rally blockade restrictions.
On Saturday, the UK recorded an additional 3,423 infections, just above the previous day’s six-month low of 3,402. In addition, only 10 coronavirus-related deaths have been recorded, the lowest total number per day since early September.
Despite the improved coronavirus background, the UK has the highest COVID-related deaths in Europe, with more than 126,500 deaths.
In France, which limits the use of the AstraZeneca vaccine to 55 years and older, a family of a 38-year-old woman who died of a blood clot in the brain after vaccination filed a criminal accusation in Toulouse seeking an investigation into manslaughter. went. ..
She is one of four French people who died of a blood clot in the weeks following AstraZeneca’s vaccination. The French National Medical Safety Agency says it is investigating these and eight other cases of severe blood clots in survivors.
MHRA’s views on the relative benefits of vaccines are shared by the European Medicines Agency. The causal relationship between abnormal blood clots in people who have been vaccinated with AstraZeneca is “unproven, but possible,” and the benefits of the vaccine outweigh the risks of side effects. The World Health Organization is also working with each country. Continue to use the jab.
Adam Finn, a pediatric professor at the University of Bristol, said that the “very rare” of blood coagulation events in the context of millions of jabs administered in the United Kingdom makes decisions very easy. It was.
“Vaccination is a much safer choice in terms of minimizing the personal risk of serious illness or death,” he said.
Angela Charlton of Paris contributed to this report.
Follow AP’s pandemic coverage below.